Searching for retatrutide science bio? Learn why Science Bio closed, what retatrutide is, its legal status, and how it compares to other research peptides.
Retatrutide is an investigational triple agonist peptide that has not been approved by the FDA for any use. The keyword "retatrutide science bio" likely comes from people searching for the compound on Science Bio, a research chemical vendor that ceased operations in 2021. Today, retatrutide remains a research-only substance, and no legitimate vendor should sell it for human consumption.
What Is Retatrutide?
Retatrutide is a synthetic peptide designed to activate three hormone receptors: GLP-1, GIP, and glucagon. This triple mechanism makes it different from earlier weight-loss drugs that target only one or two receptors. Researchers are studying retatrutide for its potential effects on body weight and metabolic markers.
Clinical trials have shown significant weight loss in participants, but the drug is still in phase 3 testing. Retatrutide is not available by prescription anywhere in the world. Any online listing for retatrutide is either a research chemical or a scam.
Why People Search for "Retatrutide Science Bio"
Science Bio was a popular supplier of research chemicals and peptides before it closed in 2021. Many users remember the site for its nootropics and research compounds, including semax. If you search for semax science bio, you will find old forum threads and reviews. Similarly, science.bio semax reddit discussions still appear in search results, even though the vendor is gone.
Because Science Bio had a reputation for third-party testing, some people wonder if it ever sold retatrutide. It did not. Retatrutide was not commercially available during Science Bio's active years, and the vendor never listed it. Any website claiming to be "Science Bio" and selling retatrutide is not the original company.
Science Bio voluntarily shut down in 2021 amid changing regulations for research chemicals. Its website no longer operates, and any current site using the name is unrelated. If you see "retatrutide science bio" in an ad, it is likely a misleading attempt to capitalize on the old brand's reputation.
Retatrutide Compared to Other Research Peptides
Researchers often compare retatrutide with other compounds studied for metabolic effects. The table below outlines key differences.
| Compound | Receptor Targets | Approval Status | Typical Research Use |
|---|---|---|---|
| Retatrutide | GLP-1, GIP, glucagon | Investigational | Obesity, metabolic studies |
| Tirzepatide | GLP-1, GIP | FDA-approved (Mounjaro, Zepbound) | Diabetes, weight management |
| Cagrilintide | Amylin analog | Investigational | Obesity, combination therapy |
| AOD-9604 | HGH fragment 177-191 | Not approved | Fat metabolism research |
When examining cagrilintide vs retatrutide vs tirzepatide, the main difference is receptor activity. Tirzepatide is already approved, while retatrutide and cagrilintide are still in trials. Another common comparison is aod 9604 vs retatrutide; AOD-9604 is a fragment of human growth hormone, while retatrutide is a full triple agonist. Some studies even explore aod 9604 and retatrutide in separate arms, but no combination product exists.
Is Retatrutide Legal to Buy?
Retatrutide is not legal to buy for personal use in the United States. The FDA has not approved it, and it is not scheduled, but selling it as a dietary supplement or drug is against the law. Research chemical vendors may sell it with a "not for human consumption" label, but that does not make it safe or legal for personal use.
Purchasing retatrutide online carries serious risks. The product may be mislabeled, contaminated, or completely fake. The FDA has warned consumers about counterfeit weight-loss peptides. Always consult a healthcare professional before considering any unapproved substance.
Safety and Clinical Status of Retatrutide
Retatrutide is still being evaluated in phase 3 trials. Reported side effects in trials include nausea, diarrhea, vomiting, and constipation. These are common with GLP-1 drugs, but long-term safety data are not yet available.
Retatrutide is not a cure for obesity or any disease. No one should use it without medical supervision. If you have questions about weight management, talk to a licensed healthcare provider.
Key Takeaways
- Retatrutide is an investigational triple agonist, not an approved drug.
- Science Bio closed in 2021 and never sold retatrutide.
- Any vendor selling retatrutide for human use is operating illegally.
- Comparisons with tirzepatide, cagrilintide, and AOD-9604 are for research only.
- Always prioritize safety and consult a healthcare professional.
Frequently Asked Questions
Does Science Bio still sell retatrutide?
No, Science Bio shut down in 2021 and never sold retatrutide. Any website claiming to be Science Bio and offering retatrutide is not the original vendor and is likely a scam.
Is retatrutide FDA approved for weight loss?
No, retatrutide is not approved by the FDA for any use. It is still in phase 3 clinical trials, and no prescription version exists.
Can I buy retatrutide legally in the US?
No, it is illegal to sell retatrutide as a drug or supplement in the US because it is not approved. Research chemical sales are a legal gray area, but personal use is not recommended and carries health risks.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.